The Barcelona-based startup Sequentia Biotech has raised €10 million ($11 million) in a Series A round to finance the ...
The Barcelona-based startup Sequentia Biotech has raised €10 million ($11 million) in a Series A round to finance the development of its omics-based technology for use in biomedicine, agritech and ...
These results back up results from the TEMPO-3 trial, which tested tavapadon as an add-on therapy to levodopa and which also ...
Designed as a next generation cellulose-based virus removal filter, Planova™ S20N has demonstrated robust filtration ...
The US biotech’s neurological drug candidate showed a reduction in disease progression of at least 50% and the company will ...
The small molecule drug arimoclomol (Miplyffa) has got the green light from the U.S. Food and Drug Administration (FDA) for ...
As department lead, I am responsible for determining the overall direction of our engineering and extraction technology team at Bioiberica. It’s a great team to lead comprised of 15 scientists, with a ...
The US big pharma company Pfizer has voluntarily withdrawn the oral sickle cell disease treatment Oxbryta from the market and halted clinical trials of the drug as data indicate a high risk of severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback